EPISODE · Jan 2, 2012 · 6 MIN
Podcast: Teva Seeks Label Change for Azilect
from The Michael J. Fox Foundation Parkinson's Podcast
This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”Mentioned in this episode:Researchers are studying the link between sense of smell and brain health. People with and without Parkinson's can help by taking a scratch-and-sniff test. It’s free, mailed to your home and takes just 15 minutes to complete. mysmelltest.org/getstarted
Embed this episode
What this episode covers
This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”
NOW PLAYING
Podcast: Teva Seeks Label Change for Azilect
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.